Vanda Pharmaceuticals
VNDA
#7801
Rank
โ‚ฌ0.31 B
Marketcap
5,32ย โ‚ฌ
Share price
-0.32%
Change (1 day)
39.90%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.94 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion206.6%
2024 -โ‚ฌ34.94 Million191.43%
2023 -โ‚ฌ11.99 Million-320.45%
2022 โ‚ฌ5.43 M-84.99%
2021 โ‚ฌ36.23 M54.8%
2020 โ‚ฌ23.4 M19.42%
2019 โ‚ฌ19.6 M4.93%
2018 โ‚ฌ18.67 M-228.6%
2017 -โ‚ฌ14.53 Million-8.98%
2016 -โ‚ฌ15.96 Million-53.79%
2015 -โ‚ฌ34.54 Million-30.18%
2014 -โ‚ฌ49.46 Million173.08%
2013 -โ‚ฌ18.12 Million-25.33%
2012 -โ‚ฌ24.26 Million163.61%
2011 -โ‚ฌ9.21 Million-221.15%
2010 โ‚ฌ7.59 M-124.53%
2009 -โ‚ฌ30.97 Million-29.44%
2008 -โ‚ฌ43.88 Million-36.2%
2007 -โ‚ฌ68.78 Million21.81%
2006 -โ‚ฌ56.47 Million170.55%
2005 -โ‚ฌ20.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.32 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.56 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.10 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.74 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.30 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.24 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.42 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA